{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T15:27:34Z","timestamp":1779118054558,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1124\/dmd.110.035501","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T04:31:32Z","timestamp":1284438692000},"page":"2166-2172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Metabolism and Action of Proteasome Inhibitors in Primary Human Hepatocytes"],"prefix":"10.1016","volume":"38","author":[{"given":"Choon-Myung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rochelle I.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward T.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.035501_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-894X(98)00029-8","article-title":"Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids","volume":"8","author":"Adams","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.110.035501_bib2","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.freeradbiomed.2007.12.010","article-title":"Roles of nitric oxide in inflammatory downregulation of human cytochromes P450","volume":"44","author":"Aitken","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/dmd.110.035501_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-\u03baB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.110.035501_bib4","first-page":"47","article-title":"Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general","volume":"2","author":"Boxenbaum","year":"1999","journal-title":"J Pharm Pharm Sci"},{"key":"10.1124\/dmd.110.035501_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1074\/jbc.272.1.182","article-title":"Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells","volume":"272","author":"Dick","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.110.035501_bib6","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1074\/jbc.271.13.7273","article-title":"Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin \u03b2-lactone","volume":"271","author":"Dick","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.110.035501_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0090-9556(25)07487-2","article-title":"Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450","volume":"24","author":"Ghosal","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.035501_bib8","first-page":"1329","article-title":"The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module","volume":"56","author":"Goodwin","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.110.035501_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.110.035501_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1081\/DMR-120033996","article-title":"Cytochrome P450: what have we learned and what are the future issues?","volume":"36","author":"Guengerich","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.110.035501_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0006-8993(02)04030-1","article-title":"Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons","volume":"964","author":"Kikuchi","year":"2003","journal-title":"Brain Res"},{"key":"10.1124\/dmd.110.035501_bib12","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1074\/jbc.M708821200","article-title":"Nitric oxide-dependent proteasomal degradation of cytochrome P450 2B proteins","volume":"283","author":"Lee","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.110.035501_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1124\/dmd.108.026187","article-title":"Dual mechanisms of CYP3A protein regulation by proinflammatory cytokine stimulation in primary hepatocyte cultures","volume":"37","author":"Lee","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.035501_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0962-8924(98)01346-4","article-title":"Proteasome inhibitors: valuable new tools for cell biologists","volume":"8","author":"Lee","year":"1998","journal-title":"Trends Cell Biol"},{"key":"10.1124\/dmd.110.035501_bib15","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.1074\/jbc.272.12.8013","article-title":"Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor \u03baB-dependent mechanism","volume":"272","author":"McKee","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.110.035501_bib16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1124\/dmd.110.035501_bib17","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1093\/nar\/21.22.5059","article-title":"Proteolytic degradation of MAD3 (I\u03baB\u03b1) and enhanced processing of the NF-\u03baB precursor p105 are obligatory steps in the activation of NF-\u03baB","volume":"21","author":"Mellits","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/dmd.110.035501_bib18","doi-asserted-by":"crossref","first-page":"10403","DOI":"10.1073\/pnas.96.18.10403","article-title":"Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity","volume":"96","author":"Meng","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.110.035501_bib19","first-page":"3276","article-title":"Enhanced I\u03baB\u03b1 degradation is responsible for constitutive NF-\u03baB activity in mature murine B-cell lines","volume":"14","author":"Miyamoto","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.110.035501_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/med.1009","article-title":"The ubiquitin-proteasome pathway and proteasome inhibitors","volume":"21","author":"Myung","year":"2001","journal-title":"Med Res Rev"},{"key":"10.1124\/dmd.110.035501_bib21","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1124\/dmd.104.002956","article-title":"Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites","volume":"33","author":"Pekol","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.035501_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0076-6879(96)72044-X","article-title":"Use of human hepatocytes to study P450 gene induction","volume":"272","author":"Strom","year":"1996","journal-title":"Methods Enzymol"},{"key":"10.1124\/dmd.110.035501_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.41.1.123","article-title":"Phenobarbital response elements of cytochrome P450 genes and nuclear receptors","volume":"41","author":"Sueyoshi","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.110.035501_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nm815","article-title":"The orphan nuclear receptor HNF4\u03b1 determines PXR- and CAR-mediated xenobiotic induction of CYP3A4","volume":"9","author":"Tirona","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/dmd.110.035501_bib25","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1124\/dmd.105.005710","article-title":"Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomib","volume":"33","author":"Uttamsingh","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.035501_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/abbi.1999.1139","article-title":"Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes","volume":"365","author":"Wang","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.110.035501_bib27","doi-asserted-by":"crossref","first-page":"13797","DOI":"10.1073\/pnas.93.24.13797","article-title":"Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate","volume":"93","author":"Werner","year":"1996","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624025583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624025583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.035501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:54:10Z","timestamp":1739897650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624025583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0090955624025583"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.035501","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism and Action of Proteasome Inhibitors in Primary Human Hepatocytes","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.035501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}